A Weill Cornell Medicine research team will receive $1.3 million over five years to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.
The third annual Cornell High School Programming Contest Warm Up, a virtual computer programming competition, was less a contest and more a chance for budding programmers to hone their skills.
Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.
Wegmans is set to open this Sunday at the Brooklyn Navy Yard in New York City. Edward McLaughlin, emeritus professor of food industry management, says given Wegmans’ supermarket innovation in service and products, New York City will now be able to relish in the legendary service, restaurant-quality prepared foods and wide selection of goods that are the envy of supermarket companies around the globe.
Cornell Tech’s first virtual Open Studio – an end-of-semester event in which students present the products they built to members of the tech industry – will be held online May 15.
People have more efficient conversations, use more positive language and perceive each other more positively when using an artificial intelligence-enabled chat tool, a group of Cornell researchers has found.
Gender Equality in Tech (GET) Cities, led by Cornell Tech-based Break Through Tech and SecondMuse, in partnership with Melinda Gates’ Pivotal Ventures, has launched GET DC as its next city hub.
A new center at Cornell will fight the rise of antibiotic resistance, a global health challenge that threatens to reverse critical advances in modern medicine.
